NYSE:HCAHealthcare
A Look At HCA Healthcare (HCA) Valuation After Strong Results Outlook And New US$10b Buyback Program
HCA Healthcare (HCA) drew fresh attention after releasing fourth quarter and full year 2025 results, reporting higher sales and net income alongside a 2026 profit outlook above analyst expectations, a new US$10b share buyback program, and an increased dividend.
See our latest analysis for HCA Healthcare.
The shares have been volatile around the earnings release, with a 1 day share price return of -1.77% taking the price to US$482.53, but a 7 day share price return of 3.47% and 90 day share...